#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Hepatoblastoma Vitamin B12 deficiency Hodgkin's disease Niemann-Pick disease Dedifferentiated liposarcoma Cardiac arrest Hairy cell leukaemia Scleroderma associated digital ulcer Idiopathic pulmonary fibrosis ROHHAD syndrome Endocrine ophthalmopathy Cutaneous lupus erythematosus Ovarian cancer stage III Rosai-Dorfman syndrome Advanced systemic mastocytosis More trials…

    Learn about Rare Diseases

    Friedreich’s ataxia Langerhans’ cell histiocytosis – Diagnostics Factor VIII deficiency – Treatment Medulloblastoma Aicardi-Goutieres syndrome – Treatment Bronchiolitis obliterans syndrome Haemophilia A without inhibitors – Trials in Disease Medulloblastoma recurrent – Trials in Disease Noonan syndrome – Trials in Disease Immunodeficiency congenital – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Glenzocimab Sar-443579 Elranatamab Umeclidinium ALE.P02 Pasireotide Diaspartate NALDEMEDINE Mepivacaine Hydrochloride Caba-201 Nivolumab Citalopram Hydrochloride Magnesium Chloride Omp65 Aripiprazole Meclofenamate Sodium Mitazalimab Benfotiamine Posaconazole CEFTAROLINE FOSAMIL Belinostat More therapies…

    Learn about Your Condition

    Pancreaticoduodenectomy Ovarian cancer recurrent B-cell lymphoma recurrent Oral lichen planus Arrhythmia Pancreatic carcinoma recurrent Myxofibrosarcoma Laryngeal cancer stage II Pancreatic carcinoma stage IV Cytomegalovirus infection Mucopolysaccharidosis Amyloidosis Abdominal infection Kearns-Sayre syndrome Pulmonary congestion More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Pre-eclampsia

  • Study on Pravastatin for Pregnant Patients with Preeclampsia or Intrauterine Growth Restriction

    Recruiting

    3 1 1
    Investigated Drugs:
    • Pravastatin Sodium
    Spain

  • Study of Metformin to Extend Pregnancy Duration in Women with Preterm Preeclampsia

    Recruiting

    3 1 1
    Investigated Diseases:
    • Eclampsia
    • Foetal exposure during pregnancy
    • Pre-eclampsia
    Investigated Drugs:
    • Metformin Hydrochloride
    The Netherlands

  • Study on Aspirin for Preventing Preeclampsia in First-Time Pregnant Women Using Assisted Reproductive Technology

    Recruiting

    3 1 1
    Investigated Diseases:
    • Pre-eclampsia
    Investigated Drugs:
    • Acetylsalicylic Acid
    France

  • Study on Aspirin for Preventing Preeclampsia in Twin Pregnancies

    Recruiting

    3 1 1
    Investigated Drugs:
    • Acetylsalicylic Acid
    Austria Belgium Bulgaria Czechia Denmark Germany +3

  • Study on Metformin for Prolonging Pregnancy in Women with Preterm Preeclampsia

    Recruiting

    3 1 1
    Investigated Diseases:
    • Pre-eclampsia
    Investigated Drugs:
    • Metformin Hydrochloride
    Finland Norway Sweden

  • Study of Acetylsalicylic Acid (Aspirin) 150 mg for Prevention of Complications in Pregnant Women with Chronic Hypertension

    Recruiting

    3 1 1
    Investigated Diseases:
    • Foetal growth restriction
    • Pre-eclampsia
    Investigated Drugs:
    • Acetylsalicylic Acid
    France
1 2
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!